F1FE1_11 Pharmacoeconomics

Faculty of Pharmacy
Spring 2022
Extent and Intensity
1/0/0. 2 credit(s). Type of Completion: z (credit).
Teacher(s)
doc. Ing. Jiří Dohnal, CSc., MBA (lecturer)
Guaranteed by
doc. Ing. Jiří Dohnal, CSc., MBA
Department of Applied Pharmacy – Departments – Faculty of Pharmacy
Timetable
Thu 24. 3. to Thu 19. 5. each even Thursday 10:15–12:35 45-135
Course Enrolment Limitations
The course is only offered to the students of the study fields the course is directly associated with.

The capacity limit for the course is 100 student(s).
Current registration and enrolment status: enrolled: 15/100, only registered: 0/100
fields of study / plans the course is directly associated with
Course objectives
To get acquainted students with the role of pharmacoeconomics in the public health, pharmacy, hospital pharmacy and pharmaceutical industry.
Learning outcomes
After completing the course, the student will be able to: - be familiar with basic pharmacoeconomic methods and tools and possibly apply them to selected examples - understand the principles of HTA and outcomes research - assess medicines for the possible entry of counterfeits into the market - understand the principles of parallel import.
Syllabus
  • -- Introduction to the study of pharmacoeconomics, case studies - HTA, outcomes research - Price and reimbursement regulation of medicines - Hospitals´ drug policy and possibilities of its effecting by pharmacist - Innovation as a source of efficiency of the health care system - Business environment in the pharmaceutical industry - Innovation as a source of efficiency of the health care system - Counterfeit medicines, parallel import
Literature
    recommended literature
  • Pharmacoeconomics Principles and Best Practices: A Practical Guide
  • Vlček, J., Dalecká, R. a kol. Základy farmakoepidemiologie, farmakoekonomiky a farmakoinformatiky. Remedia Praha, 2005. info
    not specified
  • SKOUPÁ, jana, Karolína ŠVECOVÁ and Svatava SNOPKOVÁ. Analýza nákladové efektivity pre-expoziční profylaxe infekce HIV u vysoce rizikové populace v podmínkách České republiky. Klinická mikrobiologie a infekční lékařství. Praha: Trios, spol. s.r.o., 2020, vol. 26, 13-14, p. 18-24. ISSN 1211-264X. info
  • SKOUPÁ, J, Svatava SNOPKOVÁ, P DVOŘÁK and J POSPÍŠIL. Healthcare costs of HIV in the Czech Republic. A single center analysis. ISPOR 16th Annual European Congress, 2-5 November 2013 Dublin, Ireland. (Healthcare costs of HIV in the Czech Republic. A single center analysis.). Value Health. 2013. ISSN 1098-3015. info
  • SKOUPÁ, J, V ČERNÁ, D BARTÁŠKOVÁ and Jindřich OLŠOVSKÝ. Farmakoekonomika podání inzulinu vs rosiglitazon po selhání metforminu v monoterapii u diabetes mellitus 2.typu. Farmakoekonomika. 2007, vol. 2, No 3, p. 73-76. ISSN 1211-0647. info
  • SKOUPÁ, Jana, Petr DÍTĚ, Viera ČERNÁ, Milan LUKÁŠ, Tomáš DOLEŽAL, Jana KOŽELUHOVÁ, Jiří JANKŮ, Zdeněk NĚMEČEK, Josef CHALUPA, Josef DOSEDĚL and Libor GABALEC. Finanční dopady strategií v léčbě osteoartrózy v České republice. Farmakoekonomika. Praha, 2007, vol. 2, No 2, p. 45-49. ISSN 1801-6367. info
Teaching methods
Lectures; presentations by professionals in the sectors; class discussion.
Assessment methods
Min. 80% attendance at classes. Questionnaire; credits
Language of instruction
Czech
Further comments (probably available only in Czech)
Study Materials
The course can also be completed outside the examination period.
Teacher's information
The condition for granting the credit is at least 80% attendance at lectures. In justified cases, credits will be solved individually.
The course is also listed under the following terms Spring 2020, Spring 2021.
  • Enrolment Statistics (recent)
  • Permalink: https://is.muni.cz/course/pharm/spring2022/F1FE1_11